Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Protocol No.: GB27862; "A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lebrikizumab in Patients with Uncontrolled Asthma Who are on Inhaled Corticosteriods and a Second Controller Medication"
Calhoun, William
(PI)
Internal Medicine
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
5/16/12
→
5/15/14
Funding
Genentech, Inc ( Award # ):
$293,408.00
View all
View less